Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failure
Abstract In recent years, the substantial increase in total joint replacements for treating degenerative joint disease has heightened concerns regarding implant loosening and failure. This is especially critical as more young patients are undergoing both initial and subsequent joint replacement proc...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Aggregate |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/agt2.645 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850255683762520064 |
|---|---|
| author | Javad Tavakoli Qi Hu Joanne L. Tipper Youhong Tang |
| author_facet | Javad Tavakoli Qi Hu Joanne L. Tipper Youhong Tang |
| author_sort | Javad Tavakoli |
| collection | DOAJ |
| description | Abstract In recent years, the substantial increase in total joint replacements for treating degenerative joint disease has heightened concerns regarding implant loosening and failure. This is especially critical as more young patients are undergoing both initial and subsequent joint replacement procedures. These complications often necessitate additional revision surgeries. Unfortunately, current clinical practices lack effective methods for the early detection of implant failure, and there is a noticeable absence of strategies utilizing molecular markers to identify post‐surgery implant issues. This article critically assesses the potential of aggregation‐induced emission (AIE) biomarkers in detecting molecular markers relevant to implant failure. It begins by outlining the pathogenesis of implant loosening and identifying pertinent molecular markers. The study then delves into how AIE luminogens (AIEgens) can play a crucial role in detecting processes such as osteogenesis and osteoclastogenesis. Notably, it discusses the utilization of AIEgens in detecting key molecular markers, including TNF‐α, osteocalcin, and urinary N‐terminal telopeptide. The prospect of AIE biomarkers for the early detection of bone loss and implant failure presents a promising avenue for enhancing our understanding of skeletal health and improving clinical outcomes through timely intervention and personalized treatment approaches. Ongoing research and development in this area are crucial for translating AIE‐based technologies into practical tools for optimizing bone health management. |
| format | Article |
| id | doaj-art-5738cf6669c545db93e43e2542cd17d9 |
| institution | OA Journals |
| issn | 2692-4560 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Aggregate |
| spelling | doaj-art-5738cf6669c545db93e43e2542cd17d92025-08-20T01:56:48ZengWileyAggregate2692-45602024-12-0156n/an/a10.1002/agt2.645Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failureJavad Tavakoli0Qi Hu1Joanne L. Tipper2Youhong Tang3Department of Biomedical Engineering School of Engineering RMIT University Melbourne Victoria AustraliaInstitute for NanoScale Science and Technology Medical Device Research Institute College of Science and Engineering Flinders University Adelaide South Australia AustraliaDepartment of Biomedical Engineering School of Engineering RMIT University Melbourne Victoria AustraliaInstitute for NanoScale Science and Technology Medical Device Research Institute College of Science and Engineering Flinders University Adelaide South Australia AustraliaAbstract In recent years, the substantial increase in total joint replacements for treating degenerative joint disease has heightened concerns regarding implant loosening and failure. This is especially critical as more young patients are undergoing both initial and subsequent joint replacement procedures. These complications often necessitate additional revision surgeries. Unfortunately, current clinical practices lack effective methods for the early detection of implant failure, and there is a noticeable absence of strategies utilizing molecular markers to identify post‐surgery implant issues. This article critically assesses the potential of aggregation‐induced emission (AIE) biomarkers in detecting molecular markers relevant to implant failure. It begins by outlining the pathogenesis of implant loosening and identifying pertinent molecular markers. The study then delves into how AIE luminogens (AIEgens) can play a crucial role in detecting processes such as osteogenesis and osteoclastogenesis. Notably, it discusses the utilization of AIEgens in detecting key molecular markers, including TNF‐α, osteocalcin, and urinary N‐terminal telopeptide. The prospect of AIE biomarkers for the early detection of bone loss and implant failure presents a promising avenue for enhancing our understanding of skeletal health and improving clinical outcomes through timely intervention and personalized treatment approaches. Ongoing research and development in this area are crucial for translating AIE‐based technologies into practical tools for optimizing bone health management.https://doi.org/10.1002/agt2.645aggregation‐induced emissionbiomarkersearly detectionimplant failureorthopaedic implantsosteolysis |
| spellingShingle | Javad Tavakoli Qi Hu Joanne L. Tipper Youhong Tang Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failure Aggregate aggregation‐induced emission biomarkers early detection implant failure orthopaedic implants osteolysis |
| title | Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failure |
| title_full | Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failure |
| title_fullStr | Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failure |
| title_full_unstemmed | Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failure |
| title_short | Aggregation‐induced emission biomarkers for early detection of orthopaedic implant failure |
| title_sort | aggregation induced emission biomarkers for early detection of orthopaedic implant failure |
| topic | aggregation‐induced emission biomarkers early detection implant failure orthopaedic implants osteolysis |
| url | https://doi.org/10.1002/agt2.645 |
| work_keys_str_mv | AT javadtavakoli aggregationinducedemissionbiomarkersforearlydetectionoforthopaedicimplantfailure AT qihu aggregationinducedemissionbiomarkersforearlydetectionoforthopaedicimplantfailure AT joanneltipper aggregationinducedemissionbiomarkersforearlydetectionoforthopaedicimplantfailure AT youhongtang aggregationinducedemissionbiomarkersforearlydetectionoforthopaedicimplantfailure |